ERBB2 and non-small cell lung carcinoma: In conclusion, HER-2/neu expression in NSCLC could be a bad prognostic factor in NSCLC, but assessment of c-erbB-2 expression in lung cancer presents several difficulties: the immunohistochemical techniques used to detect its expression and the criteria of positivity varying among institutions.